1. Home
  2. RLAY vs PWP Comparison

RLAY vs PWP Comparison

Compare RLAY & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.59

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$17.17

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
PWP
Founded
2015
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
RLAY
PWP
Price
$9.59
$17.17
Analyst Decision
Strong Buy
Hold
Analyst Count
7
3
Target Price
$16.86
$23.50
AVG Volume (30 Days)
2.5M
691.9K
Earning Date
05-04-2026
05-01-2026
Dividend Yield
N/A
1.60%
EPS Growth
31.78
138.52
EPS
N/A
0.47
Revenue
$15,355,000.00
N/A
Revenue This Year
N/A
$31.87
Revenue Next Year
$324.03
$17.04
P/E Ratio
N/A
$37.23
Revenue Growth
53.44
N/A
52 Week Low
$1.78
$14.44
52 Week High
$11.49
$25.93

Technical Indicators

Market Signals
Indicator
RLAY
PWP
Relative Strength Index (RSI) 49.08 41.30
Support Level $9.06 $17.05
Resistance Level $11.46 $20.33
Average True Range (ATR) 0.63 0.71
MACD -0.12 0.18
Stochastic Oscillator 16.18 61.84

Price Performance

Historical Comparison
RLAY
PWP

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

Share on Social Networks: